Phathom Pharmaceuticals

PHAT NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $1,912 $682 $0 $0
Gross Profit 1,486 905 -121 -123
EBITDA -69,740 -66,356 -35,659 -31,227
EBIT -69,954 -66,541 -35,780 -31,350
Net Income -82,852 -79,570 -43,243 -40,965
Net Change In Cash 1,912 682 0 0
Free Cash Flow -69,060 -44,272 -32,853 -22,206
Cash 322,229 381,393 213,677 248,847
Basic Shares 58,371 51,289 56,782 48,500

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $682 $0 $0 $0
Gross Profit 515 -620 -521 -300
EBITDA -159,049 -170,418 -137,095 -124,582
EBIT -159,624 -172,440 -135,080 -125,665
Net Income -201,592 -223,006 -148,094 -133,318
Net Change In Cash 682 0 0 0
Cost of Revenue -104,237 43,731
Free Cash Flow -139,214 -147,571 -148,945 -70,728
Cash 381,393 155,385 183,259 287,496
Basic Shares 51,289 39,118 37,002 33,228

Earnings Calls

Quarter EPS
2024-03-31 -$1.42
2023-12-31 -$1.39
2023-09-30 -$0.76
2023-06-30 -$0.84